Sionna Therapeutics (SION) Retained Earnings (2024 - 2026)
Sionna Therapeutics (SION) posted Retained Earnings of -$283.1 million for Q1 2026, down 10.45% sequentially from -$256.4 million in Q4 2025, and down 151.57% YoY from $549.0 million in Q1 2025.
Sionna Therapeutics (SION) Retained Earnings (2024 - 2026) Analysis & Trends
Sionna Therapeutics has reported Retained Earnings for 3 years, with the latest figure at -$283.1 million in Q1 2026.
- Quarterly Retained Earnings fell 151.57% year-over-year to -$283.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$283.1 million (down 151.57% YoY) and the FY2025 annual result came in at -$256.4 million, down 69761.41% from the prior year.
- Retained Earnings slipped to -$283.1 million in Q1 2026 per SION's latest filing, from -$256.4 million in the prior quarter.
- Over five years, Retained Earnings peaked at $549.0 million in Q1 2025 and troughed at -$283.1 million in Q1 2026.
- A 3-year average of $1.7 million and a median of $275500.0 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2025 and 2026: Retained Earnings slumped 69761.41% in 2025, then tumbled 151.57% in 2026.
- Over 3 years, Retained Earnings stood at $368000.0 in 2024, then plunged by 69761.41% to -$256.4 million in 2025, then slipped by 10.45% to -$283.1 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$283.1 million, -$256.4 million, and $420000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Sionna Therapeutics | 291.76 Mn | 291.76 Mn | - | 579.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 579.20 Mn |
| Mar 31, 2026 | -283.13 Mn |
| Dec 31, 2025 | -256.35 Mn |
| Sep 30, 2025 | 420,000.00 |
| Jun 30, 2025 | 183,000.00 |
| Mar 31, 2025 | 548.99 Mn |
| Dec 31, 2024 | 368,000.00 |